Cytoplasmic p53 polypeptide is associated with ribosomes

Molecular and Cellular Biology

Volumn 17, Issue 6, 1997, Pages 3146-3154

  Fontoura, Beatriz M A ^a   Atienza, Cesar A ^a   Sorokina, Elena A ^a   Morimoto, Takashi ^a   Carroll, Robert B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; DODECYL SULFATE SODIUM; MESSENGER RNA; PROTEIN P53; PROTEINASE K; PUROMYCIN; RIBONUCLEASE; RNA 5.8S;

ANIMAL CELL; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; COVALENT BOND; EMBRYO; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; RAT; RIBOSOME; TUMOR SUPPRESSOR GENE;

EID: 0030924724     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.6.3146     Document Type: Article

References (60)

1. Barber, G. N., M. Wambach, M.-L. Wong, T. E. Dever, A. G. Hinnebusch, and M. G. Katze. 1993. Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. Proc. Natl. Acad. Sci. USA 90:4621-4625.
2. Bargonetti, J., J. J. Manfredi, X. Chen, D. R. Marshak, and C. Prives. 1994. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7:2565-2574.
3. Bayle, J. H., B. Elenbaas, and A. J. Levine. 1995. The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc. Natl. Acad. Sci. USA 92:5729-5733.
4. Bienz, B., R. Zakut-Houri, D. Givol, and M. Oren. 1984. Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J. 3:2179-2183.
5. Bienz-Tadmor, B., R. Zakut-Houri, S. Libresco, D. Givol, and M. Oren. 1985. The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. EMBO J. 4:3209-3213.
6. Carroll, R. B., and E. G. Gurney. 1982. Time-dependent maturation of the simian virus 40 large T antigen-p53 complex studied by using monoclonal antibodies. J. Virol. 44:565-573.
7. Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355.
8. Clore, G. M., J. G. Omichinski, K. Sakaguchi, N. Zambrano, H. Sakamoto, E. Appella, and A. M. Gronenborn. 1994. High resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science 265:386-391.
9. Craig, N. 1975. Regulation of translation in rabbit reticulocytes and mouse L-cells; comparison of the effects of temperature. J. Cell. Physiol. 87:137-166.
10. De Benedetti, A., and R. E. Rhoads. 1990. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. USA 87:8212-8216.
11. Dever, T. E., L. Feng, R. C. Wek, A. M. Cigan, T. F. Donahue, and A. G. Hinnebusch. 1992. Phosphorylation of initiation factor 2α by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 68:585-596.
12. Eliyahu, D., N. Goldfinger, O. Pinhasi-Kimhi, G. Shaulsky, V. Skurnik, N. Arai, V. Rotter, and M. Oren. 1988. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3:313-321.
13. 1 cell-cycle arrest. Genes Dev. 9:204-217.
14. Fields, S., and S. K. Jang. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049.
15. Fontoura, B. M. A., E. A. Sorokina, E. David, and R. B. Carroll. 1992. p53 is covalently linked to 5.8S rRNA. Mol. Cell. Biol. 12:5145-5151.
16. Friedman, P. N., X. Chen, J. Bargonetti, and C. Prives. 1993. The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc. Natl. Acad. Sci. USA 90:3319-3323.
17. Fritsch, M., C. Haessler, and G. Brandner. 1993. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307-318.
18. Ginsberg, D., D. Michael-Michalovitz, D. Ginsberg, and M. Oren. 1991. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol. Cell. Biol. 11:582-585.
19. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264-6277.
20. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-438.
21. Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546.
22. Hershey, J. W. B. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717-755.
23. Ikeda, J.-E., A. Yudelevich, N. Shimamoto, and J. Hurwitz. 1979. Role of polymeric forms of the bacteriophage fX174 coded gene A protein in fXRF1 DNA cleavage. J. Biol. Chem. 254:9416-9428.
24. Jeffrey, P. D., S. Gorina, and N. Pavletich. 1995. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267:1498-1502.
25. Kastan, M. Personal communication.
26. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
27. Koromilas, A. E., S. Roy, G. N. Barber, M. G. Katze, and N. Sonenberg. 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685-1689.
28. Kozak, M. 1992. Regulation of translation in eukaryotic systems. Annu. Rev. Cell Biol. 8:197-225.
29. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491-7495.
30. Lane, D. P. 1992. Cancer. p53, guardian of the genome. Nature 358:15-16.
31. Lin, D., M. T. Shields, S. J. Ullrich, E. Appella, and W. E. Mercer. 1992. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl. Acad. Sci. USA 89:9210-9214.
32. Lin, J., J. Chen, B. Elenbaas, and A. J. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1235-1246.
33. Lindquist, S., and R. Petersen. 1990. Selective translation and degradation of heat-shock messenger RNAs in Drosophila. Enzyme 44:147-166.
34. Maltzman, W., and L. Czyzyk. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1689-1694.
35. Marechal, V., B. Elenbaas, J. Piette, J.-C. Nicolas, and A. J. Levine. 1994. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14:7414-7420.
36. McGarry, T. J., and S. Linquist. 1985. The preferential translation of Drosophila hsp70 mRNA requires sequences in the untranslated leader. Cell 42:903-911.
37. Metspalu, A., I. Toots, M. Saarma, and R. Villems. 1980. The ternary complex consisting of rat liver ribosomal 5S RNA, 5.8S RNA and protein L5. FEBS Lett. 119:81-34.
38. Meurs, E. F., J. Galabru, G. N. Barber, M. G. Katze, and A. G. Hovanessian. 1993. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 90:232-236.
39. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
40. Mosner, J., T. Mummenbrauer, C. Bauer, G. Sczakiel, F. Grosse, and W. Deppert. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:4442-4449.
41. Nelson, R. J., T. Ziegelhoffer, C. Nicolet, M. Werner-Washburne, and E. A. Craig. 1992. The translation machinery and 70 kd heat shock protein cooperate in protein synthesis. Cell 71:97-105.
42. 40a. Nelson, W. G., and M. B. Kastan. 1994. DNA strand breaks: DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1815-1823.
43. Nigro, J. M., S. Baker, A. C. Presinger, J. M. Jessup, R. Hosteller, S. Cleary, S. H. Bigner, N. Davidson, S. Baylin, P. Devillee, T. Glover, F. S. Collins, A. Weston, R. Modali, C. C. Harris, and B. Vogelstein. 1989. Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705-708.
44. Oberosler, P., P. Hloch, U. Ramsperger, and H. Stahl. 1993. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12: 2389-2396.
45. O'Rourke, R. W., C. W. Miller, G. J. Kato, K. J. Simon, D.-L. Chen, C. V. Chang, and H. P. Koeffler. 1990. A potential transcriptional activation element in the p53 protein. Oncogene 5:1829-1832.
46. Pavletich, N. P., K. A. Chambers, and C. O. Pabo. 1993. The DNA binding domain of p53 contains the four conserved regions and the major mutation hotspots. Genes Dev. 7:2556-2564.
47. Pene, J. J., E. Knight, and J. E. Darnell. 1968. Characterization of a new molecular weight RNA in HeLa ribosomcs. J. Mol. Biol. 33:609-623.
48. Raycroft, L., H. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051.
49. Samad, A., C. W. Anderson, and R. B. Carroll. 1986. Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from SV40-transformed 3T3 cells. Proc. Natl. Acad. Sci. USA 83:897-901.
50. Samad, A., and R. B. Carroll. 1991. The tumor suppressor p53 is bound to RNA by a stable covalent linkage. Mol. Cell. Biol. 11:1598-1606.
51. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
52. Shaulsky, G., A. Ben-Ze'ev, and V. Rotter. 1990. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5:1707-1711.
53. Shaulsky, G., N. Goldfinger, A. Ben-Ze'Ev, and V. Rotter. 1990. Nuclear accumulation of p53 is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10:6565-6577.
54. Sturzbecher, H. W., R. Brain, C. Addison, V. K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J. R. Jenkins. 1992. A C-terminal alpha helix plus basic motif is the major structural determinant of p53 tetramerization. Oncogene 7:1513-1523.
55. Tan, T.-H., J. Wallis, and A. J. Levine. 1986. Identification of the p53 protein domain involved in formation of the simian virus 40 large T antigen-p53 protein complex. J. Virol. 59:574-583.
56. Tzamarias, D., I. Roussou, and G. Thireos. 1989. Coupling of GCN4 mRNA translational activation with decreased rates of polypeptide chain initiation. Cell 57:947-954.
57. Ulrich, N., A. Lui, and I. G. Wool. 1979. Identification by affinity chromatography of the eukaryotic ribosomal proteins that bind to 5.8S ribosomal ribonucleic acid. J. Biol. Chem. 254:8641-8645.
58. Walker, K., S. A. Elela, and R. N. Nazar. 1990. Inhibition of protein synthesis by anti-5.8S rRNA oligo-deoxyribonucleotides. J. Biol. Chem. 265:2428-2430.
59. Wang, Y., M. Reed, P. Wang, J. E. Stenger, G. Mayr, M. E. Anderson, J. F. Sehwedes, and P. Tegtmeyer. 1994. p53 domains: identification and characterization of two autonomous DNA binding regions. Genes Dev. 7:2575-2586.
60. Wu, L., J. H. Bayle, B. Elenbaas, N. P. Pavletich, and A. J. Levine. 1995. Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids. Mol. Cell. Biol. 15:497-504.